Pharmaxis Ltd PMXSF
0.03 USD 0.00 (+0.00%)
At closeFeb 4, 2026, 4:00 PM EST
0.026 Day range 0.026
0.026 52-week range 0.026
- YTD
- 0.00%
- 1 year
- 0.00%
News
seekingalpha.com Syntara Limited (PMXSF) Q4 2026 Earnings Call Transcript Syntara Limited (PMXSF) Q4 2026 Earnings Call Transcript
seekingalpha.com Syntara Limited (PMXSF) Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder Transcript Syntara Limited (PMXSF) Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder Transcript
seekingalpha.com Syntara Limited (PMXSF) Shareholder/Analyst Call Prepared Remarks Transcript Syntara Limited (PMXSF) Shareholder/Analyst Call Prepared Remarks Transcript
seekingalpha.com Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
seekingalpha.com Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
seekingalpha.com Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates Transcript Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates Transcript
seekingalpha.com Syntara Limited (PMXSF) Discusses Progress and Future Plans for Skin Scarring Program Transcript Syntara Limited (OTCPK:PMXSF) Discusses Progress and Future Plans for Skin Scarring Program November 25, 2025 7:00 PM EST Company Participants Gary Phillips - CEO, MD & Director Wolfgang Jarolimek -…
seekingalpha.com Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript Syntara Limited (OTCPK:PMXSF) Shareholder/Analyst Call November 19, 2025 6:00 PM EST Company Participants Cameron Billingsley - Company Secretary & General Counsel Kathleen M. Metters Gary Phillips -…